Literature DB >> 8253749

Purification and characterization of CMP-N-acetylneuraminic acid:lactosylceramide (alpha 2-3) sialyltransferase (GM3-synthase) from rat brain.

U Preuss1, X Gu, T Gu, R K Yu.   

Abstract

CMP-N-acetylneuraminic acid:lactosylceramide (alpha 2-3) sialyltransferase (GM3-synthase) was purified to homogeneity from a Triton CF-54 extract of young rat brain. The enzyme was separated by affinity chromatography on CDP-Sepharose column and resolved by linear NaCl gradient elution from the same adsorbent. Final purification of GM3-synthase was achieved by chromatography on a "lactosylceramide acid"-Sepharose column and specific elution with lactosylceramide. The enzyme activity was highest at pH 6.5 and required the presence of Triton CF-54 (0.15%) and Mn2+ (10 mM) for its full activity. The product of the reaction catalyzed by the enzyme was identified as GM3 based on its mobility on thin layer chromatographic plates using two different solvent systems. Comparison with several glycolipid substrates showed high specificity of GM3-synthase for lactosylceramide. The apparent Km value for lactosylceramide and CMP-N-acetylneuraminic acid were 80 and 210 microM, respectively. The apparent molecular mass of the enzyme determined on SDS-polyacrylamide gel electrophoresis was 76 kDa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253749

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

2.  Quantitative transcriptomic profiling of branching in a glycosphingolipid biosynthetic pathway.

Authors:  Hiromu Takematsu; Harumi Yamamoto; Yuko Naito-Matsui; Reiko Fujinawa; Kouji Tanaka; Yasushi Okuno; Yoshimasa Tanaka; Mamoru Kyogashima; Reiji Kannagi; Yasunori Kozutsumi
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

3.  Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation.

Authors:  G Zeng; T Ariga; X B Gu; R K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

Review 4.  Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.

Authors:  A D Rhim; L Stoykova; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

5.  Zebrafish and mouse alpha2,3-sialyltransferases responsible for synthesizing GM4 ganglioside.

Authors:  Shin-ichi Chisada; Yukihiro Yoshimura; Keishi Sakaguchi; Satoshi Uemura; Shinji Go; Kazutaka Ikeda; Hiroyuki Uchima; Naoyuki Matsunaga; Kiyoshi Ogura; Tadashi Tai; Nozomu Okino; Ryo Taguchi; Jinichi Inokuchi; Makoto Ito
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

6.  Enhancing of GM3 synthase expression during differentiation of human blood monocytes into macrophages as in vitro model of GM3 accumulation in atherosclerotic lesion.

Authors:  Elena V Gracheva; Nelya N Samovilova; Natalia K Golovanova; Svetlana V Kashirina; Alexander Shevelev; Igor Rybalkin; Tat'yana Gurskaya; Tat'yana N Vlasik; Elena R Andreeva; Nina V Prokazova
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

7.  Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.

Authors:  Milan Raska; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Rose Kulhavy; Judit Andrasi; Stacy Hall; Huong L Vu; Fredric Carlsson; Gunnar Lindahl; Milan Tomana; Bruce A Julian; Robert J Wyatt; Jiri Mestecky; Jan Novak
Journal:  J Mol Biol       Date:  2007-03-12       Impact factor: 5.469

8.  A new assay for determining ganglioside sialyltransferase activities lactosylceramide-2,3-sialyltransferase (SAT I) and monosialylganglioside-2,3-sialyltransferase (SAT IV).

Authors:  Cynthia Q Sun; Ulrike Hubl; Petra Hoefakker; Madhusudan K Vasudevamurthy; Keryn D Johnson
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.